pharmaphorum

APRIL 8, 2021

COVID-19 has been a trial-by-fire showing just how quickly drugs and vaccines can be developed under the right circumstances – but there is much to do to ensure this progress is not lost, said speakers at WIRED Health 2021, including the CEOs of BioNTech and BenevolentAI. . We published our hypothesis in the Lancet on February 4 in 2020.

Development 82

Development Drugs Vaccination Vaccine 82

XTalks

AUGUST 5, 2020

Coupling single cell omics with other omics technologies and machine learning tools such as artificial intelligence (AI) can provide key insights about cellular and molecular targets that drive diseases. The barcode sequence is followed by a unique molecular identifier, which enables accurate digital counting of gene transcripts.

Gene Expression 112

Gene Expression Development RNA Drugs 112

Pharma Marketing Network

JUNE 10, 2020

He’s the Chief Digital Officer for Health at Ogilvy. So I love talking to you because you’ve got your pulse on the finger of everything that’s happening digitally within healthcare, you always open my eyes to interesting things that are happening. And that reduces a time of drug discovery from 10 years to five years.

Marketing 52

Marketing Clinical Trials Clinical Trials Nurses 52

Pharma Marketing Network

JUNE 10, 2020

He’s the Chief Digital Officer for Health at Ogilvy. So I love talking to you because you’ve got your pulse on the finger of everything that’s happening digitally within healthcare, you always open my eyes to interesting things that are happening. And that reduces a time of drug discovery from 10 years to five years.

Marketing 40

Marketing Clinical Trials Clinical Trials Nurses 40

pharmaphorum

NOVEMBER 3, 2022

Food and Drug Administration’s (FDA) draft guidance, “ Digital Health Technologies for Remote Data Acquisition in Clinical Investigations ”. The Digital Medicine Society’s Library of Digital Endpoints surpassed 350 unique digital endpoints used for evaluating new medical products. Moving towards implementation.

Clinical Trials 81

Clinical Trials Clinical Trials Trials Medicine 81

Drug Discovery World

NOVEMBER 13, 2023

On Day 3, Thursday 16 November 2023, the tracks include: the second part of machine learning for protein engineering, antibodies against membrane protein targets, engineering bispecific antibodies, next-generation immunotherapies, protein stability and formulation, and protein process development.

Protein 59

Protein Antibody Engineer Scientist 59

Drug Discovery World

APRIL 11, 2024

On the final day of AACR, the plenary session of the Annual Meeting put artificial intelligence at the forefront and featured a stellar lineup of AI and data science experts who discussed AI and topics such as imaging, precision medicine, and drug development.

HR 52

HR Antibody In-Vitro DNA 52

XTalks

DECEMBER 22, 2021

Formulas can be generated in days and clinical-grade manufacturing can be accomplished in weeks. billion in 2021, a figure that has already been overtaken by the two leading mRNA COVID-19 vaccines alone, to $101.3 That’s why it requires careful handing at the lab bench and storage at double digit sub-zero temperatures.

Life Science 98

Life Science RNA Vaccination Vaccine 98

Delveinsight

AUGUST 11, 2021

With technological advancements like Artificial Intelligence (AI) in operation , few regular issues that existed earlier like ‘patient waiting time’ are decreasing and ‘staff efficiency’ is increasing. Drug Development. Nowadays this process is achieved by AI and machine learning , leading to immense support in drug development.

Medicine 90

Medicine Drug Delivery Development Drug Delivery Systems 90

XTalks

AUGUST 2, 2023

In the last quarter of 2021, Pfizer underwent a change in their global structure and now manages their commercial operations through two segments: Biopharma, the innovative biopharmaceutical business, and PC1, their global contract development and manufacturing branch (and lead supplier of active pharmaceutical ingredients).

Sales 98

Sales Manufacturing FDA Approval Life Science 98

Drug Discovery World

NOVEMBER 18, 2022

Here, DDW Editor Reece Armstrong looks at the current state of drug resistance and what’s been happening within pharma to curb this threat. Ultimately, the goal for the AMR Action Fund is to help bring two to four new antibiotics to market by 2030. So where are we? . Speaking about the research, Professor Sebastian Hiller?from

Bacteria 52

Bacteria Drugs Development Research 52

XTalks

DECEMBER 24, 2020

From isolating SARS-CoV-2 in early January to sequencing its genome shortly thereafter and having a prototype vaccine against it within days, scientific process and progress have held steadfast throughout the pandemic. Infectious disease expert, epidemiologist and director of the Yale Institute for Global Health at Yale University, Saad B.

Life Science 111

Life Science Vaccination Vaccine Gene 111